Lin Mei, MD

Khorasanchi A, Mullick Chowdhury S, Fei Hong E, Li M, Jiang C, Mei L, Liu MA, Collier KA, Shang C, Xu L, Manne A, Wang P, Jaroniec S, Gong M, Singer EA, Hong F, Kim H, Niazi K, Wesolowski R, Rubinstein M, Yang Y, Meng L. Circulating Tumor DNA Clearance Is Associated with Response and Survival in Metastatic Urothelial Carcinoma Treated with First-Line Enfortumab Vedotin Plus Pembrolizumab , Cancers, 18(21): 2026,3532

Meng L, Malone X, Peng H, Mei L, Jiang C, Liu X, Wang QE, Hong F, Sood A, Wang SJ, Wu Q, Wang S, Wang P. Racial Disparities in Survival Outcomes for Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A SEER-Based Retrospective Analysis (2010-2020) , Cancers (Basel), 18: 2026,2884

Du W, Koga S, Walle S, Mei L, Baloch Z. Clinicopathologic, immunohistochemical, and molecular correlates in resected primary adrenocortical carcinoma: a single-institution cohort study , Virchows Arch: 2026

Flaig TW, Spiess PE, Abern M, An Y, Bangs R, Begovic J, Brown J, Buyyounouski MK, Chan K, Chang P, Chin AI, Guru KA, Herr HW, Hoffman-Censits J, Kaimakliotis H, Kundu S, Lele SM, Luckenbaugh A, Maldonado J, Mei L, Montgomery JS, Parikh M, Patterson A, Peyton C, Plimack ER, Preston MA, Richards K, Seyedin S, Siefker-Radtke AO, Stewart T, Sundi D, Swami U, Tollefson M, Wright JL, Cassara CJ, Sliker B. Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology , J Natl Compr Canc Netw: 2026

Litt HK, Wodzinski A, Subramanian P, Donovan M, Vapiwala N, Narayan V, Mei L, Takvorian S, Haas NB, Parikh RB, Mistry R, Mamtani R. OncoEducate: A Pilot Study of Generative AI to Enhance Patient-Clinician Communication in Genitourinary Cancer Care , Oncologist: 2026

Nair RP, Du W, Mei L, Koga S. Artificial intelligence for detection, grading, and prognostication in prostate cancer pathology: A scoping review , Histol Histopathol: 2026

Mo G, Maier S, Doyle M, Sweeney S, Orellana J, Farago L, Lloyd A, Mawema H, Bajaj A, Mei L, Takvorian SU, Haas NB, Ky B, Leong D, Narayan V. Cardiovascular risk evaluation in men with prostate cancer study (CARE-PC): Pilot study to assess patient awareness and risk mitigation. , 2026 American Society of Clinical Oncology Genitourinary Cancers Symposium, San Fran, CA.: 2026

Litt HK, Wodzinski A, Subramanian P, Donovan M, Vapiwala N, Parikh RB, Narayan V, Mei L, Takvorian SU, Balzer Haas N, Mistry R, and Mamtani R. OncoEducate: A pilot study of generative AI to support patient education in GU cancer care. , 2026 American Society of Clinical Oncology Genitourinary Cancers Symposium, San Fran, CA., 44(7): 2026,713

Subramanian P, Barsouk A, Elghawy O, Sussman JH, Yaskolko M, Yang A, Xu J, and Mei L. EGFR, HER2 alterations in advanced urothelial carcinoma (aUC): A retrospective analysis on survival outcomes. , American Society of Clinical Oncology Genitourinary Cancers Symposium, San Fran, CA., 44(7): 2026,787

Barsouk AA, Yang A, Sussman JH, Elghawy O, Xu J, Xu J, Meng L, Koga S, Du W, Mamtani R, Mei L. Survival Disparities by Sex, Race, and Age in the Era of Contemporary Advanced Urothelial Carcinoma Therapy: A Real-World Analysis , Clin Genitourin Cancer, 23(5): 2025,102395